Moreabout:
BiopharmaceuticalStatisticsEncyclopediaofBiopharmaceuticalStatistics,SecondEdition(Print)
by:Shein-ChungChow
ByShein-ChungChowPublisher:InformaHealthCare
NumberOfPages:1000
PublicationDate:2003-06-04
ISBN-10/ASIN:0824742613
ISBN-13/EAN:9780824742614
ProductDescription:MillenniumPharmaceuticals,Cambridge,MA.Resourceoffersmorethan3,300listsexpandedtoreflectamendmentstoregulatoryrequirementsandrecentlydevelopedstatisticalmethodsimpactingthedrugreview/approvalprocessandbiopharmaceuticalresearchanddevelopment.Offersmorethan3,000equations,tables,andfigures.Previouseditionnotcited/
Summary:excellentcompendiumonstatmethodsinbiostatistics
Rating:5ChowhasdoneanexcellentjobofcollectingarticlesfromtheleadingresearchersinthepharmaceuticalandbiologicsindustryincludingFDAemployees.Thetermsarespecializedbutimportanttothoseindustries.Thearticlesarescholarlyandinformative.ThequalityissimilartothoseintheEncyclopediaofStatisticalScience.Mostofthetermsarealsoofinteresttostatisticianslikemyselfwhoworkinthemedicaldeviceindustry.Asampleoftheitemsare"AdjustmentforCovariates","BayesianStatistics","Bioassay","ClinicalTrials","EquivalenceTrials","FoodandDrugAdministration","Intention-to-TreatAnalyses","InternationalConferenceonHarmonization","MultipleComparisons","PostmarketingSurveillance","SampleSizeDetermination",and"SurrogateEndpoint".
ThisisaparticularlygoodreferenceforstatisticianswhoworkonclinicaltrialsregulatedbytheFDA.Howeverkeepinmindthatitisveryspecializedandisratherexpensive.Summary:providesarticlesonstatisticaltermsusedindrugstudies
Rating:5ChowhasdoneanexcellentjobofcollectingarticlesfromtheleadingresearchersinthepharmaceuticalandbiologicsindustryincludingFDAemployees.Thetermsarespecializedbutimportanttothoseindustries.Thearticlesarescholarlyandinformative.ThequalityissimilartothoseintheEncyclopediaofStatisticalScience.Mostofthetermsarealsoofinteresttostatisticianslikemyselfwhoworkinthemedicaldeviceindustry.Asampleoftheitemsare"AdjustmentforCovariates","BayesianStatistics","Boassay","ClinicalTrials","EquivalenceTrials","FoodandDrugAdministration","Intention-to-TreatAnalyses","InternationalConferenceonHarmonization","MultipleComparisons","PostmarketingSurveillance","SampleSizeDetermination",and"SurrogateEndpoint".ThisisaparticularlygoodreferenceforstatisticianswhoworkonclinicaltrialsregulatedbytheFDA.Howeverkeepinmindthatitisveryspecializedandisratherexpensive.
